Greenleaf Peter

SVP, Sales and Marketing at MEDIMMUNE INC /DE · on record since Jun 19, 2007
Director at Pelthos Therapeutics Inc. · on record since Apr 1, 2026
Director at Sucampo Pharmaceuticals, Inc. · on record since Mar 5, 2014
Director at Savara Inc · on record since Nov 9, 2015
Director at SYNLOGIC, INC. · on record since Mar 14, 2016
Director at Avalo Therapeutics, Inc. · on record since May 16, 2017
Chief Executive Officer at Avalo Therapeutics, Inc. · on record since Mar 29, 2018
Chief Executive Officer at Sucampo Pharmaceuticals, Inc. · on record since Feb 13, 2018
Director at BIODELIVERY SCIENCES INTERNATIONAL INC · on record since May 23, 2018
Director at KIORA PHARMACEUTICALS INC · on record since Jul 19, 2018
Director at ALTIRIS INC · on record since Dec 14, 2018
Director at Aurinia Pharmaceuticals Inc. · on record since Jan 4, 2021
Chief Executive Officer at Aurinia Pharmaceuticals Inc. · on record since Jan 4, 2021

Insider trading activity of Greenleaf Peter

Transactions on record: 113; since May 23, 2006

Open-market buys: 3; $104.6K

Open-market sells: 12; $7.7M

Companies traded: 10; last filing Jul 7, 2026

Figures computed from official regulatory filings — .

Companies where Greenleaf Peter has traded

Pelthos Therapeutics Inc.7 tx · $37.5K · Jul 7, 2026
Aurinia Pharmaceuticals Inc.22 tx · $9M · Mar 3, 2026
ALTIRIS INC13 tx · $711K · May 26, 2022
18 tx · $418.5K · Mar 22, 2022
12 tx · $49.8K · Oct 3, 2019
2 tx · Feb 5, 2019
28 tx · $19.1M · Feb 13, 2018
4 tx · Jan 23, 2017
3 tx · Sep 6, 2016
4 tx · Jun 19, 2007

Track record of Greenleaf Peter

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Greenleaf Peter

Co-insiders of Greenleaf Peter

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Pelthos Therapeutics Inc.Listing unverified	Jul 7, 2026	Sell	-85	27.27 USD	$2.3K	SEC
Pelthos Therapeutics Inc.Listing unverified	Jul 7, 2026	Sell	-712	26.00 USD	$18.5K	SEC
Pelthos Therapeutics Inc.Listing unverified	Apr 6, 2026	Sell	-377	21.36 USD	$8.1K	SEC
Pelthos Therapeutics Inc.Listing unverified	Apr 6, 2026	Sell	-420	20.52 USD	$8.6K	SEC
Pelthos Therapeutics Inc.Listing unverified	Apr 1, 2026	Award	25,478	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 3, 2026	Other	-100,890	14.21 USD	$1.4M	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 3, 2026	Award	196,403	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 3, 2026	AwardD (derivative)	328,424	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Feb 23, 2026	Other	-100,171	14.40 USD	$1.4M	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Jan 5, 2026	Other	-113,169	15.95 USD	$1.8M	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Jan 5, 2026	Award	165,384	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Pelthos Therapeutics Inc.Listing unverified	Jul 7, 2025	AwardD (derivative)	77,640	—	n/a (No price was disclosed in the filing)	SEC
Pelthos Therapeutics Inc.Listing unverified	Jul 7, 2025	AwardD (derivative)	25,478	—	n/a (No price was disclosed in the filing)	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 4, 2025	Award	333,705	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 4, 2025	Sell	-195,593	8.00 USD	$1.6M	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 4, 2025	AwardD (derivative)	443,973	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 4, 2025	Award	290,728	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 4, 2025	Sell	-164,947	7.92 USD	$1.3M	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 7, 2024	Sell	-126,981	5.60 USD	$711.1K	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Feb 22, 2024	Sell	-33,047	8.78 USD	$290.2K	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Feb 22, 2024	Award	661,538	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 6, 2023	Award	667,407	—	n/a (No price was disclosed in the filing)	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 6, 2023	Sell	-32,750	8.94 USD	$292.8K	SEC
ALTIRIS INCListing unverified	May 26, 2022	Other	-30,220	5.60 USD	$169.2K	SEC
ALTIRIS INCListing unverified	May 26, 2022	OtherD (derivative)	-58,246	—	n/a (No price was disclosed in the filing)	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Pelthos Therapeutics Inc.Listing unverified	Jul 7, 2026	Sell	-85	27.27 USD	$2.3K	SEC
Pelthos Therapeutics Inc.Listing unverified	Jul 7, 2026	Sell	-712	26.00 USD	$18.5K	SEC
Pelthos Therapeutics Inc.Listing unverified	Apr 6, 2026	Sell	-377	21.36 USD	$8.1K	SEC
Pelthos Therapeutics Inc.Listing unverified	Apr 6, 2026	Sell	-420	20.52 USD	$8.6K	SEC
Pelthos Therapeutics Inc.Listing unverified	Apr 1, 2026	Award	25,478	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 3, 2026	Other	-100,890	14.21 USD	$1.4M	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 3, 2026	Award	196,403	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 3, 2026	AwardD (derivative)	328,424	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Feb 23, 2026	Other	-100,171	14.40 USD	$1.4M	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Jan 5, 2026	Other	-113,169	15.95 USD	$1.8M	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Jan 5, 2026	Award	165,384	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Pelthos Therapeutics Inc.Listing unverified	Jul 7, 2025	AwardD (derivative)	77,640	—	n/a (No price was disclosed in the filing)	SEC
Pelthos Therapeutics Inc.Listing unverified	Jul 7, 2025	AwardD (derivative)	25,478	—	n/a (No price was disclosed in the filing)	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 4, 2025	Award	333,705	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 4, 2025	Sell	-195,593	8.00 USD	$1.6M	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 4, 2025	AwardD (derivative)	443,973	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 4, 2025	Award	290,728	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 4, 2025	Sell	-164,947	7.92 USD	$1.3M	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 7, 2024	Sell	-126,981	5.60 USD	$711.1K	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Feb 22, 2024	Sell	-33,047	8.78 USD	$290.2K	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Feb 22, 2024	Award	661,538	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 6, 2023	Award	667,407	—	n/a (No price was disclosed in the filing)	SEC
Aurinia Pharmaceuticals Inc.Listing on record	Mar 6, 2023	Sell	-32,750	8.94 USD	$292.8K	SEC
ALTIRIS INCListing unverified	May 26, 2022	Other	-30,220	5.60 USD	$169.2K	SEC
ALTIRIS INCListing unverified	May 26, 2022	OtherD (derivative)	-58,246	—	n/a (No price was disclosed in the filing)	SEC